Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-39.55%
Negative revenue growth while PGN.DE stands at 89.62%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
2.50%
Gross profit growth under 50% of PGN.DE's 52.63%. Michael Burry would be concerned about a severe competitive disadvantage.
33.44%
Positive EBIT growth while PGN.DE is negative. John Neff might see a substantial edge in operational management.
33.44%
Positive operating income growth while PGN.DE is negative. John Neff might view this as a competitive edge in operations.
32.34%
Net income growth under 50% of PGN.DE's 216.23%. Michael Burry would suspect the firm is falling well behind a key competitor.
42.86%
Positive EPS growth while PGN.DE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
42.86%
Positive diluted EPS growth while PGN.DE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
20.00%
Share change of 20.00% while PGN.DE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
20.00%
Diluted share change of 20.00% while PGN.DE is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.06%
10Y revenue/share CAGR under 50% of PGN.DE's 253.70%. Michael Burry would suspect a lasting competitive disadvantage.
-63.81%
Negative 5Y CAGR while PGN.DE stands at 123.75%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-85.05%
Negative 3Y CAGR while PGN.DE stands at 58.37%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
1.71%
Positive OCF/share growth while PGN.DE is negative. John Neff might see a comparative advantage in operational cash viability.
-8.28%
Negative 3Y OCF/share CAGR while PGN.DE stands at 209.77%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-347.96%
Negative 10Y net income/share CAGR while PGN.DE is at 1118.63%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-432.19%
Negative 5Y net income/share CAGR while PGN.DE is 877.41%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-253.07%
Negative 3Y CAGR while PGN.DE is 644.25%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
-1.66%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-79.36%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-28.39%
Firm’s AR is declining while PGN.DE shows 24.56%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
6903.06%
Inventory growth well above PGN.DE's 28.32%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
133.54%
Positive asset growth while PGN.DE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-28.93%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
103.74%
Debt growth far above PGN.DE's 7.30%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-12.66%
We cut SG&A while PGN.DE invests at 68.58%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.
1.14 - 1.17
1.10 - 1.60
14.0K / 2.1K (Avg.)
-9.00 | -0.13